There are currently 139 clinical trials in Newark, New Jersey looking for participants to engage in research studies. Trials are conducted at various facilities, including Newark Beth Israel Medical Center, Rutgers New Jersey Medical School, Saint Michael's Medical Center and University Hospital. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
NCT03412643
Recruiting
This is a prospective, single arm, open label, multicenter interventional study designed to evaluate the efficacy of neoadjuvant chemotherapy with anti-HER2 antibodies in patients with HER2-negative invasive breast cancer who have abnormal HER2 signaling activity determined by the Celcuity CELx HER2 Signaling Function (HSF) testing.
Gender:
Female
Ages:
18 years and above
Trial Updated:
03/03/2023
Locations: Newark Beth Israel Medical Center, Newark, New Jersey
Conditions: HER2-negative Breast Cancer
Register for Updates
Serious Games for Parkinson's Disease
NCT05551338
Recruiting
IMPORTANCE: Rehabilitation games have been shown to improve cognitive function among people with various disorders but they have not been explored in home settings for patients with Parkinson's disease. OBJECTIVE: To collect pilot data regarding the therapeutic benefits of self-administered rehabilitation games among patients with Parkinson's disease. METHODS: The investigators will recruit 20 patients with Parkinson's disease into a pilot randomized controlled trial. Patients will be asked to... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
09/19/2022
Locations: Rutgers University, Newark, New Jersey
Conditions: Parkinson Disease, Parkinson
Register for Updates
Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders
NCT04231487
Recruiting
The purpose of the research is to better understand the motor behavior of individuals in health and disease. The specific purpose of this project is to identify if we can utilize a smartphone to diagnose different movement disorders and monitor their symptoms. A. Objectives Estimate symptom severity of Essential tremor (ET), Parkinson's disease (PD), Huntington's disease (HD), Primary focal dystonia (PFD), spinocerebellar ataxia (SCA), and Functional movement disorders (FMD) using a smartphone... Read More
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
09/19/2022
Locations: Rutgers University, Newark, New Jersey
Conditions: Essential Tremor, Parkinson Disease, Huntington Disease, Dystonia, Primary, Spinocerebellar Ataxias, Movement Disorders
Register for Updates
Tele-yoga and Dystonia
NCT04348669
Recruiting
The purpose of this study is to investigate the effect of yoga delivered remotely on adults with dystonia. This work will have implications related to physical interventions symptom management and quality of life as well as implications related to the role of tele-therapy.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
09/16/2022
Locations: Motor Behavior Laboratory, Newark, New Jersey
Conditions: Cervical Dystonia
Register for Updates
Evaluation of the FELLAS Responsible Fatherhood Project
NCT05412641
Recruiting
The Partnership for Maternal and Child Health of Northern New Jersey, Inc. (PMCH) is implementing a fatherhood project with the goal of strengthening father-child engagement, improving economic stability, and improving healthy marriage/relationship skills among participants. FELLAS serves community-based fathers 18 years of age or older who reside in Essex County, New Jersey and have at least one child under the age of 24. The program model has three components: to improve responsible parenting... Read More
Gender:
Male
Ages:
18 years and above
Trial Updated:
06/07/2022
Locations: Partnership for Maternal & Child Health of Northern New Jersey, Newark, New Jersey
Conditions: Responsible Fatherhood
Register for Updates
Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL
NCT03911076
Recruiting
To evaluate the safety and tolerability of the dual IM pNGVL4a Sig/E7(detox)/HSP70 DNA and single IM TA-CIN immunization regimen To evaluate the efficacy of dual IM pNGVL4a-Sig/E7(detox)/HSP70 DNA and single IM TA-CIN immunization regimen on Human Papillomavirus (HPV) 16 clearance by Month 6
Gender:
Female
Ages:
Between 25 years and 70 years
Trial Updated:
04/19/2022
Locations: University Hospital, Rutgers New Jersey Medical School, Newark, New Jersey
Conditions: ASC-US, ASC-H Atypical Squamous Cells, Cannot Rule Out High-Grade Squamous Intra-Epithelial Lesion, LSIL
Register for Updates
NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection
NCT04452565
Recruiting
This Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechanical ventilation) with SARS CoV-2 infection, in which participants will receive NA-831 or Atazanavir with or without Dexamethasone.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
01/31/2022
Locations: Coronavirus Research Institute-Testing Site, Newark, New Jersey
Conditions: Coronavirus Infection, Severe Acute Respiratory Infection, Severe Acute Respiratory Syndrome Coronavirus 2
Register for Updates